Publications by authors named "Luca Franceschini"

17Publications

Recurrent Sweet's syndrome in a patient with multiple myeloma.

Clin Case Rep 2018 Oct 21;6(10):1958-1960. Epub 2018 Aug 21.

Department of Biomedicine and Prevention University of Rome Tor Vergata Rome Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/ccr3.1764DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6186870PMC
October 2018

Nephelometric assay of urine free light chains: an alternative and early clinical test for Bence-Jones protein quantification.

Clin Chem Lab Med 2018 11;56(12):e313-e315

Department of Experimental Medicine and Surgery, "Tor Vergata" University Hospital, Rome, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1515/cclm-2018-0402DOI Listing
November 2018

Minimal tumour burden in haematological diseases: a step forward with quantitative assessment of Bence-Jones in nephelometry?

Br J Haematol 2016 11 18;175(4):733-735. Epub 2015 Dec 18.

Department of Experimental Medicine and Surgery, "Tor Vergata" University, Rome, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/bjh.13878DOI Listing
November 2016

Pre-treatment staging of multiple myeloma patients: comparison of whole-body diffusion weighted imaging with whole-body T1-weighted contrast-enhanced imaging.

Acta Radiol 2015 Jun 27;56(6):733-8. Epub 2014 Jun 27.

University Hospital Policlinico Tor Vergata, Department of Diagnostic Imaging, Molecular Imaging, Interventional Radiology and Radiation Therapy, University of Rome "Tor Vergata", Rome, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1177/0284185114538792DOI Listing
June 2015

Bortezomib-melphalan-prednisone-thalidomide followed by maintenance with bortezomib-thalidomide compared with bortezomib-melphalan-prednisone for initial treatment of multiple myeloma: updated follow-up and improved survival.

J Clin Oncol 2014 Mar 21;32(7):634-40. Epub 2014 Jan 21.

Antonio Palumbo, Sara Bringhen, Alessandra Larocca, Valeria Magarotto, Paola Omedé, Roberto Mina, Mario Boccadoro, and Giulia Benevolo, Azienda Ospedaliera (A.O.) Città della Salute e della Scienza di Torino; Daniela Gottardi, A.O. Ordine Mauriziano; Roberto Passera, San Giovanni Battista Hospital, University of Torino, Torino; Davide Rossi and Gianluca Gaidano, Amedeo Avogadro University of Eastern Piedmont, Novara; Francesco Di Raimondo, Ferrarotto Hospital, University of Catania, Catania; Francesca Patriarca, A.O. Universitaria, Udine; Anna Levi and Maria Teresa Petrucci, Sapienza University of Rome; Luca Franceschini, Tor Vergata University Hospital, Rome; Iolanda Donatella Vincelli, A.O. Bianchi-Melacrino-Morelli, Reggio Calabria; Mariella Grasso, S. Croce e Carle Hospital, Cuneo; Renato Zambello, Università degli Studi di Padova, Padova; Vittorio Montefusco, Istituto Di Ricovero e Cura a Carattere Scientifico (IRCCS) Istituto Nazionale dei Tumori Milano, University of Milano, Milan; Antonietta Pia Falcone, IRCCS Casa Sollievo della Sofferenza and Unità di Ematologia, San Giovanni Rotondo; Roberto Marasca, University of Modena, Modena; Fortunato Morabito, A.O. di Cosenza, Cosenza; Tommasina Guglielmelli, "S. Luigi Gonzaga" Hospital, Orbassano; Chiara Nozzoli, A.O. Universitaria Careggi, Firenze; Massimo Offidani, Ospedali Riuniti, Ancona; Roberto Ria, University of Bari "Aldo Moro" Medical School, Bari; Pellegrino Musto, IRCCS-Centro Regionale Oncologico Basilicata, Rionero in Vulture; and Michele Cavo, Università degli Studi di Bologna, Policlinico S. Orsola-Malpighi, Bologna, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2013.52.0023DOI Listing
March 2014